-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Opinion: Cardiovascular disease is the next great challenge for HIV care
Cardiovascular (CV) disease is a leading cause of death of people with HIV. Dr. Steven Grinspoon calls for better understanding of the causes and highlights a promising trial.
-
‘Human Knockout Project’ in a Pakistani Population with High Levels of Consanguinity
Experimental “knockout” models are useful to study gene function. This poster highlights naturally-occurring null mutations and their phenotypic consequences in humans.
-
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
Myocardial Infarction contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
#ACC18 Video: Scientific Session in Summary
-
James Louis Januzzi, MD
Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
ACC.18: Eight Sessions to See
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Instructor of Medicine, Harvard Medical School
Recent Article
Expanding the Primary Prevention Role of Lifestyle and Statins to Reduce First Cardiac Event Risk
-
Sekar Kathiresan, MD
Director of the Center for Genomic Medicine , Ofer and Shelley Nemirovsky MGH Research Scholar, Director of the Cardiovascular Disease Initiative at the Broad institute
Recent Article
Increasing the Accuracy of Genetic Cardiovascular Fortune-Telling
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
